Hogarty M D, Maris J M, White P S, Guo C, Brodeur G M
Division of Oncology, Children's Hospital of Philadelphia, Pennsylvania 19104-4318, USA.
Med Pediatr Oncol. 2001 Jan;36(1):52-5. doi: 10.1002/1096-911X(20010101)36:1<52::AID-MPO1014>3.0.CO;2-8.
Deletion of the distal short arm of chromosome 1 occurs in 25-35% of primary neuroblastomas, and a putative tumor suppressor gene has been mapped to a consensus region of deletion at 1p36.2-36.3. Indirect evidence suggests the presence of an imprinted neuroblastoma suppressor gene within this region, as well as an additional nonimprinted, proximal suppressor gene, inactivation of which correlates with MYCN amplification.
To test this hypothesis, we performed 1p loss of heterozygosity (LOH) studies on a series of neuroblastomas for which parental DNA had been collected. PCR-formatted polymorphic markers were used to determine the size of the 1p deletion and the parental origin of the deleted 1p homologue.
Twenty-six neuroblastomas with 1p LOH were evaluated. Twenty-four had MYCN amplification, and of these, 15 demonstrated loss of the paternally inherited 1p. Two neuroblastomas with a single copy of MYCN were evaluated and both had deletion of the paternally inherited 1p, with one case exhibiting a small terminal deletion. In addition, we have reviewed 49 previously reported neuroblastomas where 1p LOH data and the parental origin of the deleted lp homologue were available.
Analyzed together, these 75 neuroblastomas demonstrate random deletion of parental 1p homologues (P = 0.30). Further, tumors with smaller deletions (breakpoints distal to D1S201 or D1S7) showed a random loss of the parental 1p homologues (P = 0.59), contrary to the expected preferential maternal 1p deletion if an imprinted suppressor gene mapped to this region. However, 19 tumors with 1p LOH and single copy MYCN had deletion of the maternal 1p homologue preferentially (P = 0.02), which does not exclude the possibility that loss of an imprinted suppressor gene plays a role in this subset.
1号染色体远端短臂缺失发生于25% - 35%的原发性神经母细胞瘤中,一个假定的肿瘤抑制基因已被定位于1p36.2 - 36.3的缺失共有区域。间接证据表明该区域存在一个印记神经母细胞瘤抑制基因,以及另一个非印记的近端抑制基因,其失活与MYCN扩增相关。
为验证这一假说,我们对一系列已收集亲本DNA的神经母细胞瘤进行了1p杂合性缺失(LOH)研究。采用PCR格式的多态性标记来确定1p缺失的大小以及缺失的1p同源物的亲本来源。
对26例具有1p LOH的神经母细胞瘤进行了评估。其中24例有MYCN扩增,在这些病例中,15例显示父系遗传的1p缺失。对2例具有单拷贝MYCN的神经母细胞瘤进行了评估,二者均有父系遗传的1p缺失,其中1例表现为小的末端缺失。此外,我们回顾了49例先前报道的神经母细胞瘤,这些病例有1p LOH数据以及缺失的lp同源物的亲本来源信息。
综合分析,这75例神经母细胞瘤显示亲本1p同源物的随机缺失(P = 0.30)。此外,具有较小缺失(断点在D1S201或D1S7远端)的肿瘤显示亲本1p同源物的随机缺失(P = 0.59),这与如果一个印记抑制基因定位于该区域时预期的母系1p优先缺失相反。然而,19例具有1p LOH和单拷贝MYCN的肿瘤优先出现母系1p同源物缺失(P = 0.02),这并不排除印记抑制基因缺失在这一亚组中起作用的可能性。